From doing some #research https://t.co/F8rfWKLt7m to making changes in #practice https://t.co/BuwZj8cAq8 . Love seeing our work used in practice @School_Pharmacy @Ian_HKU @drkamzaki
Open Access UCL Research: Immunotherapy and associated immune-related adverse events at a large UK centre: a mixed methods study - UCL Discovery https://t.co/kfZkN8wOOO
Open Access UCL Research: Immunotherapy and associated immune-related adverse events at a large UK centre: a mixed methods study - UCL Discovery https://t.co/FQ4Dj5eaHW
Pinkie Chambers: https://t.co/0qFBSaUES9
RT @PinkieChambers: @BruceGeoB Sorry plugging our recent paper on irAEs and patient experience https://t.co/fXH2rosU1R
@BruceGeoB Sorry plugging our recent paper on irAEs and patient experience https://t.co/fXH2rosU1R
Really important to report adverse drug events to improve treatment at patient level and safety at wider level @MHRAmedicines
RT @PinkieChambers: @BOPACommittee @OncologyForum @UKONSmember need to keep patients reporting IrAEs
RT @PinkieChambers: @BOPACommittee @OncologyForum @UKONSmember need to keep patients reporting IrAEs
RT @PinkieChambers: @BOPACommittee @OncologyForum @UKONSmember need to keep patients reporting IrAEs https://t.co/rR1OWs4Z9d
@BOPACommittee @OncologyForum @UKONSmember need to keep patients reporting IrAEs
Reporting matters. @PinkieChambers et al. urge to remind patients to report adverse events timely even when innocuous; AEs can occur at any cycle and even following treatment completion 👉 https://t.co/tnGl0sxY3N @LizJamieson2 @annelouoconnor @Ian_HKU @SN
RT @drkamzaki: our paper in @BMC_series #bmccancer showed that non-serious immunotherapy related adverse events are reported late, implying…
RT @drkamzaki: our paper in @BMC_series #bmccancer showed that non-serious immunotherapy related adverse events are reported late, implying…
RT @drkamzaki: our paper in @BMC_series #bmccancer showed that non-serious immunotherapy related adverse events are reported late, implying…
RT @PinkieChambers: Our work precovid showed patients were slow in reporting #irAE - #better education & #proms could improve this @RdppU…
RT @drkamzaki: our paper in @BMC_series #bmccancer showed that non-serious immunotherapy related adverse events are reported late, implying…
RT @PinkieChambers: @BOPACommittee I loved being part of the #team in this study with @WePharmacists playing major roles in grant writing @…
RT @PinkieChambers: Our work precovid showed patients were slow in reporting #irAE - #better education & #proms could improve this @RdppU…
our paper in @BMC_series #bmccancer showed that non-serious immunotherapy related adverse events are reported late, implying a potential benefit for real time benefit, well@done @PinkieChambers @BOPACommittee for her hard work https://t.co/8hF2Xctpmd #imm
@BOPACommittee I loved being part of the #team in this study with @WePharmacists playing major roles in grant writing @jenny_d12 and patient recruitment @annelouoconnor shows what a great #research infrastructure can do @CMORE2improve @cheesmansj https://t
Our work precovid showed patients were slow in reporting #irAE - #better education & #proms could improve this @RdppU @CMORE2improve @drkamzaki https://t.co/mSKW3qtmXv